Few & Far Between: Conversations from the Front Lines of Drug Development
Chris O'Brien
35 episodes
1 week ago
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
All content for Few & Far Between: Conversations from the Front Lines of Drug Development is the property of Chris O'Brien and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation
Few & Far Between: Conversations from the Front Lines of Drug Development
44 minutes 53 seconds
3 months ago
Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation
Is the epigenome the "software" of the cell nucleus?
Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Jim Brown, President and CEO of DURECT Corporation, for a conversation on the importance of a pharmacoeconomic strategy, developing new treatments for alcohol associated hepatitis, and moving beyond what a single individual can do in clinical research.
Tune in today!
Few & Far Between: Conversations from the Front Lines of Drug Development
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
